Making space for underrepresented students in population health
September 24, 2021. "Over the summer, one dozen aspiring population health researchers -- college students from around the country who are underrepresented in the field -- worked with faculty mentors at Stanford Medicine to design and carry out research projects focused on topics such as ovarian cancer outcomes in Black women. Together they formed the first cohort of students to participate in the Advancing Health Equity and Diversity program." David Rehkopf is interviewed.
Read the Stanford Scope Blog post
Michelle Odden awarded new R01
September 20, 2021. E&PH faculty researcher Michelle Odden [pictured here] was awarded a Multiple PI RO1 (R01HL151564) for "Mitochondrial health, cardiovascular risk, and blood pressure targets in hypertensive adults," starting September 1st. Other PIs include Vasantha Jotwani (UCSF) and Greg Tranah (California Pacific Medical Center), and Co-Investigator James Zou (Biomedical Data Science).
Read more about Dr. Odden
Stanford researchers to improve LGBTQ+ health and representation
September 9, 2021. "The National Institutes of Health has awarded Stanford researchers Mitchell R. Lunn, MD, and Juno Obedin-Maliver, MD, $2.1 million in funding for the first year to recruit, retain, research and improve practices for representing LGBTQ+ people in the All of Us Research Program. The project is expected to last five years."
Access the Stanford Scope Blog post
Anticipated spill from deteriorating Red Sea oil tanker threatens public health, Stanford-led study finds
October 11, 2021. An oil spill from the FSO Safer could increase cardiovascular and respiratory hospitalizations and disrupt access to food and water for millions of people, researchers predict. This Stanford Medicine News Center release features Benjamin Huynh and David Rehkopf, and references research by Mathew Kiang and colleagues.
Access the release
Women with genetic mutations fare no worse with breast or ovarian cancer, study finds
October 1, 2021. Newly diagnosed breast or ovarian cancer patients who carry common cancer-associated mutations have similar or better short-term survival rates than those with no mutations, researchers report. E&PH faculty researcher Allison Kurian is featured.
Access the Stanford Medicine news release
Insulin resistance doubles risk of major depressive disorder, Stanford study finds
September 22, 2021. "About 1 in 3 American adults has insulin resistance, a silent time bomb that doubles their risk for serious depression, Stanford scientists have learned." Authors include Epidemiology & Clinical Research program alumna Kathleen Watson, and E&PH faculty researchers Julia Simard and Victor Henderson.
Access the Stanford Medicine News release
U.S. Food and Drug Administration Reasoning in Approval Decisions When Efficacy Evidence Is Borderline, 2013–2018
September 21, 2021. A new Annals of Internal Medicine study from Stanford epidemiologist Steven Goodman, MD, MHS, PhD, and colleagues critiques the FDA's approach to approval decisions and suggests there is no tradition, structure, or predictability to ensure consistency of decisions.
Access the publication
Melissa Bondy appointed to new AACR Working Group
September 13, 2021. The American Association for Cancer Research (AACR) announced the formation of its eighth and newest scientific working group, specifically dedicated to supporting cancer prevention research. The mission of the AACR Cancer Prevention Working Group (CPWG) is to establish cancer prevention as a global priority through innovative science, integration of the latest technologies, improved levels of funding, and delivery of effective public education and awareness strategies. E&PH Chair Melissa Bondy has been appointed a member of the AACR Cancer Prevention Working Group Steering Committee.
Access the AACR press release
Autumn 2021 Epi Seminars
Our Epidemiology Research Seminars (EPI 236, formerly HRP 236) resumed September 21st. This is a weekly forum for ongoing epidemiologic research by faculty, staff, guests, and students, emphasizing research issues relevant to disease causation, prevention, and treatment.
For upcoming event details, as they become available, reference our program web calendar.
E&PH JEDI Town Hall on “Centering Justice and Equity as We Return to Campus”
Friday, October 29, 2021
Department faculty/student/staff members will be convening for our Fall Justice, Equity, Diversity & Inclusion (JEDI) Town Hall, which will feature remarks from Shaila Kotadia, PhD, Director of JEDI for the SoM, and Terrance Mayes, EdD, Inaugural Associate Dean for Equity and Strategic Initiatives and Executive Director of the SoM Commission on Justice and Equity. These remarks will be followed by breakout discussion sessions on topics relating to our return to campus.
Read more about our department JEDI activities
E&PH Pre-Application Information Sessions for MS/PhD Programs
This is an opportunity for prospective students to meet with Stanford E&PH faculty to discuss the admission process and get answers to their questions. We will demystify the application process and help applicants highlight their strengths and unique contributions. Our faculty will present an overview of admissions and answer pre-submitted questions before finally facilitating break-out session discussions. Attendees must pre-register, and the first part of the presentation will be recorded and posted after the session. Interested parties can register here.
October 13, 2021. E&PH faculty members Patricia Rodriguez Espinosa and Lisa Goldman Rosas are collaborating with community health workers to promote COVID-19 vaccine awareness and public health guidelines in the area’s Latinx community. Watch the video and read the Stanford Report.
On October 4th, Steve Goodman gave a special vocal performance at the first in-person performance of the Stuck@Home Concert Series at Bing Concert Hall. (See the 1 hour 10 minute mark). Read more about the event.
September 16, 2021. Lisa Kim checks in with Stanford Medicine professor of infectious diseases, Stephen Luby, MD, to discuss which masks – surgical masks or cloth masks – are most effective in impeding the spread of COVID-19. Read Dr. Luby's New York Times Op Ed on mask wearing.
*If you would like to submit items for this E&PH News Bulletin or other department communications channels, please fill out this webform. Reach out to our Communications Manager, Katie M. Kanagawa (firstname.lastname@example.org), with any questions.